Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

CUSIP: G8807B106

Q1 2018 13F Holders as of 31 Mar 2018

Holder snapshot 7 signals
Share change
+809,910
Put/Call ratio
14%
SEC-reported price per share
$24.25
Number of holders
85
Value change
+$19,411,519
Number of buys
45
Open additional details 1 more signal available
Number of sells
32
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
51,428,000

Security key

G8807B106

Report period

Q1 2018

Institutions

85

Top holders

10

Ownership snapshot

Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Woodford Investment Manag...
Disclosed value leader
Woodford Investment Manag...
Comparable rows
15/15
Latest evidence
31 Dec 2017
13F Lead comparable stake: 21% Showing 1-6 of 15 holder rows.

Quick read

Woodford Investment Management Ltd leads the comparable SEC ownership view at 21%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Woodford Investment Management Ltd's linked filing trail.
Comparable ownership Top 5
Woodford Investment Management Ltd 21%
BAUPOST GROUP LLC/MA 18%
FMR LLC 15%
BlackRock Finance, Inc. 7.3%
VANGUARD GROUP INC 6.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Woodford Investment Management Ltd
13F
Company
13F
21%
$299,737,000
10,747,108 shares
31 Dec 2017
BAUPOST GROUP LLC/MA
13F
Company
13F
18%
$259,633,000
9,309,168 shares
31 Dec 2017
FMR LLC
13F
Company
13F
15%
$221,822,000
7,953,484 shares
31 Dec 2017
BlackRock Finance, Inc.
13F
Company
13F
7.3%
$104,419,000
3,743,955 shares
31 Dec 2017
VANGUARD GROUP INC
13F
Company
13F
6.6%
$94,779,000
3,398,332 shares
31 Dec 2017
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
4.5%
$64,580,000
2,315,540 shares
31 Dec 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
85
Shares
47,702,533
Rows available
85
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
79
Q1 2018 holders
85
Holder diff
6
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 value Q1 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .